91˿Ƶ

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians

A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of 91˿Ƶ and Martine Tétreault, PhD, at Université de Montréal has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.

Classified as: Ziv Gan-Or
Published on: 18 Mar 2025

On March 13, the Government of Canada, announced more than $308 million to advance science and research across the country. More than $153 million will support 179 new and renewed  at 38 research institutions.

Published on: 17 Mar 2025

Co-Principal Investigators Manisha Pahwa, CIHR Research Excellence, Diversity, and Independence Postdoctoral Fellow in the School of Physical and Occupational Therapy, and Professor Ananya Banerjee, from 91˿Ƶ's Department of Epidemiology, Biostatistics, and Occupational Health, have been awarded $449,604 from the Canadian Cancer Society’s

Published on: 17 Feb 2025

Montreal, February 13, 2025 – 91˿Ƶ’s DNA to RNA Initiative (D2R) and 91˿Ƶ Interdisciplinary Initiative in Infection and Immunity (MI4) have awarded $500,000 to fund five high-impact research projects aimed at advancing the understanding of Mpox through its Rapid Response for Mpox Research funding program.

Classified as: mpox, Research and Innovation, RNA therapeutics
Published on: 13 Feb 2025

Yesterday, HBHL hosted the first Neurogenesis Speaker Series talk of 2025 at The Neuro, featuring Paul Massetand Pouya Bashivan.

Published on: 7 Feb 2025

The D2R (DNA to RNA) Initiative has awarded more than $6 million to support eight Core Platforms at 91˿Ƶ and one at the University of British Columbia through its Core Platform Sustainability funding program. This program supports state-of-the-art Core Platforms that are essential for advancing research and development and facilitating technology uptake and transfer in fields relevant to RNA therapeutics.

Classified as: Core Platforms, RNA, RNA therapeutics, Research and Innovation
Published on: 7 Feb 2025

On January 21, the Natural Sciences and Engineering Research Council of Canada (NSERC), announced over $74 million in funding to support 107 quantum science projects, including fifteen to 91˿Ƶ researchers.

Classified as: Faculty of Science, Faculty of Engineering
Published on: 21 Jan 2025

The Office of the Vice-President (Research and Innovation) created a new University-wide prize for outstanding emerging researchers in 2013 to encourage and celebrate our most outstanding early-career researchers.

Classified as: President's Prize for Outstanding Remerging Researchers
Published on: 20 Dec 2024

Montreal – December 19, 2024– The D2R (DNA to RNA) Initiative is proud to announce the recipients of its latest round of funding, awarding a total of $1.5 million to four principal investigators and five 91˿Ƶ Centres and Institutes. These awards are designed at advancing research in RNA therapeutics by facilitating industry collaboration and supporting the next generation of scientific leaders as well as research Centres and Institutes.

Classified as: Commercialization, Innovation and Partnerships, D2R, DNA
Published on: 19 Dec 2024
Governor General recognizes 91˿Ƶ community members for exceptional accomplishments and service

Fourteen members of the 91˿Ƶ community have been appointed to the Order of Canada, one of the country’s highest civilian honours.

Among the honourees are the University’s Chancellor and three professors:

Classified as: Order of Canada, Faculty of Medicine and Health Sciences, Office for Science and Society
Published on: 18 Dec 2024

91˿Ƶ’s Vice-President of Research and Innovation recognized for transformative leadership in Canadian research

Classified as: Faculty of Engineering
Published on: 16 Dec 2024

Montréal, November 28th – CQDM is proud to announce a strategic partnership with the D2R (DNA to RNA) Initiative at 91˿Ƶ, aimed at funding translational research projects carried out through collaborations between researchers and industry. This alliance seeks to support and accelerate the development and commercialization of innovative RNA-based therapies. It aims to provide patients with safer and more effective therapeutic options, particularly for treating cancer, rare diseases, and preventing various infectious diseases.

Classified as: D2R, DNA, Research and Innovation, Innovation and Partnerships
Published on: 28 Nov 2024

Researchers’ outstanding contributions to science and society celebrated by the Fonds de recherche du Québec

Classified as: FRQ, Faculty of Medicine and Health Sciences, Faculty of Engineering
Published on: 14 Nov 2024

Pages

Back to top